Bremer Bank National Association trimmed its position in shares of McKesson Co. (NYSE:MCK – Free Report) by 92.1% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 945 shares of the company’s stock after selling 11,016 shares during the quarter. Bremer Bank National Association’s holdings in McKesson were worth $539,000 at the end of the most recent reporting period.
A number of other institutional investors also recently bought and sold shares of the company. Wolff Wiese Magana LLC raised its holdings in shares of McKesson by 742.9% in the third quarter. Wolff Wiese Magana LLC now owns 59 shares of the company’s stock worth $29,000 after acquiring an additional 52 shares during the last quarter. MidAtlantic Capital Management Inc. acquired a new position in shares of McKesson in the third quarter worth $29,000. RPg Family Wealth Advisory LLC acquired a new position in shares of McKesson in the third quarter worth $31,000. ORG Wealth Partners LLC acquired a new position in shares of McKesson in the third quarter worth $40,000. Finally, Bruce G. Allen Investments LLC raised its holdings in shares of McKesson by 51.9% in the fourth quarter. Bruce G. Allen Investments LLC now owns 82 shares of the company’s stock worth $47,000 after acquiring an additional 28 shares during the last quarter. 85.07% of the stock is currently owned by hedge funds and other institutional investors.
Analyst Ratings Changes
A number of research firms have recently weighed in on MCK. Baird R W raised McKesson from a “hold” rating to a “strong-buy” rating in a report on Thursday, November 7th. Evercore ISI boosted their price target on McKesson from $560.00 to $680.00 and gave the stock an “outperform” rating in a report on Thursday, November 7th. Wells Fargo & Company upped their price target on McKesson from $535.00 to $641.00 and gave the stock an “equal weight” rating in a research note on Friday, December 13th. Deutsche Bank Aktiengesellschaft dropped their price target on McKesson from $623.00 to $579.00 and set a “buy” rating for the company in a research note on Wednesday, September 25th. Finally, Mizuho initiated coverage on McKesson in a research note on Wednesday, December 4th. They set a “neutral” rating and a $630.00 price target for the company. Two analysts have rated the stock with a hold rating, fourteen have assigned a buy rating and one has issued a strong buy rating to the company’s stock. According to data from MarketBeat.com, McKesson presently has an average rating of “Moderate Buy” and an average target price of $646.14.
McKesson Price Performance
Shares of NYSE MCK opened at $592.69 on Monday. McKesson Co. has a 1-year low of $464.42 and a 1-year high of $637.51. The business has a 50-day moving average of $595.11 and a 200-day moving average of $561.17. The company has a market capitalization of $75.24 billion, a price-to-earnings ratio of 30.69, a PEG ratio of 1.26 and a beta of 0.52.
McKesson (NYSE:MCK – Get Free Report) last issued its quarterly earnings data on Wednesday, November 6th. The company reported $7.07 earnings per share for the quarter, beating analysts’ consensus estimates of $6.88 by $0.19. McKesson had a negative return on equity of 207.50% and a net margin of 0.77%. The firm had revenue of $93.65 billion during the quarter, compared to analyst estimates of $89.33 billion. During the same quarter last year, the firm earned $6.23 EPS. McKesson’s quarterly revenue was up 21.3% on a year-over-year basis. Research analysts expect that McKesson Co. will post 32.73 EPS for the current fiscal year.
McKesson Announces Dividend
The firm also recently disclosed a quarterly dividend, which was paid on Thursday, January 2nd. Shareholders of record on Monday, December 2nd were paid a dividend of $0.71 per share. The ex-dividend date of this dividend was Monday, December 2nd. This represents a $2.84 dividend on an annualized basis and a yield of 0.48%. McKesson’s dividend payout ratio (DPR) is presently 14.71%.
Insider Buying and Selling at McKesson
In other McKesson news, EVP Leann B. Smith sold 579 shares of the firm’s stock in a transaction that occurred on Thursday, January 2nd. The stock was sold at an average price of $572.79, for a total transaction of $331,645.41. Following the completion of the sale, the executive vice president now owns 864 shares in the company, valued at $494,890.56. This trade represents a 40.12 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. 0.11% of the stock is owned by insiders.
About McKesson
McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products.
Read More
- Five stocks we like better than McKesson
- How to Calculate Options Profits
- Unusual Call Option Volume in US Steel: Potential Upside Ahead?
- What Are Some of the Best Large-Cap Stocks to Buy?
- 3 Energy Storage Stocks Charging the Renewable Energy Sector
- How to Choose Top Rated Stocks
- Telecom Titans: Comparing Verizon and AT&T for Growth Potential
Want to see what other hedge funds are holding MCK? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for McKesson Co. (NYSE:MCK – Free Report).
Receive News & Ratings for McKesson Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for McKesson and related companies with MarketBeat.com's FREE daily email newsletter.